Quest Diagnostics Incorporated
DGX · NYSE
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Revenue | $2,816 | $2,761 | $2,652 | $2,621 |
| % Growth | 2% | 4.1% | 1.2% | – |
| Cost of Goods Sold | $1,867 | $1,818 | $1,789 | $1,763 |
| Gross Profit | $949 | $943 | $863 | $858 |
| % Margin | 33.7% | 34.2% | 32.5% | 32.7% |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $0 | $0 | $0 | $0 |
| SG&A Expenses | $501 | $486 | $476 | $466 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $62 | $19 | $41 | $31 |
| Operating Expenses | $563 | $505 | $517 | $497 |
| Operating Income | $386 | $438 | $346 | $361 |
| % Margin | 13.7% | 15.9% | 13% | 13.8% |
| Other Income/Exp. Net | -$50 | -$45 | -$52 | -$57 |
| Pre-Tax Income | $336 | $393 | $294 | $304 |
| Tax Expense | $77 | $97 | $59 | $68 |
| Net Income | $245 | $282 | $220 | $222 |
| % Margin | 8.7% | 10.2% | 8.3% | 8.5% |
| EPS | 2.18 | 2.51 | 1.97 | 1.98 |
| % Growth | -13.1% | 27.4% | -0.5% | – |
| EPS Diluted | 2.16 | 2.47 | 1.94 | 1.95 |
| Weighted Avg Shares Out | 112 | 112 | 111 | 111 |
| Weighted Avg Shares Out Dil | 113 | 113 | 113 | 113 |
| Supplemental Information | – | – | – | – |
| Interest Income | $3 | $2 | $5 | $7 |
| Interest Expense | $69 | $69 | $72 | $72 |
| Depreciation & Amortization | $142 | $143 | $140 | $135 |
| EBITDA | $547 | $596 | $488 | $507 |
| % Margin | 19.4% | 21.6% | 18.4% | 19.3% |